Effectiveness of neuraminidase inhibitors to prevent mortality in patients with laboratory-confirmed avian influenza A H7N9
Objectives: Avian influenza virus A(H7N9) remains a threat to humans and has great potential to cause a pandemic in the foreseeable future. Antiviral treatment with neuraminidase inhibitors has been recommended to treat patients with H7N9 infection as early as possible, although evidence-based resea...
Main Authors: | Wei Cheng, Anqi Pan, Stephen L. Rathbun, Yang Ge, Qian Xiao, Leonardo Martinez, Feng Ling, Shelan Liu, Xiaoxiao Wang, Zhao Yu, Mark H. Ebell, Changwei Li, Andreas Handel, Enfu Chen, Ye Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220325510 |
Similar Items
-
Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex
by: Sphamandla E. Mtambo, et al.
Published: (2022-03-01) -
Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
by: Yulia Desheva, et al.
Published: (2022-09-01) -
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
by: Madhusudan Rajendran, et al.
Published: (2017-05-01) -
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
by: Madhusudan Rajendran, et al.
Published: (2021-08-01) -
Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01)